ArticleCureus2026

Regulatory Perspectives in Precision Oncology: Challenges and Opportunities for Tyrosine Receptor Kinase (NTRK) Inhibitors in Non-small Cell Lung Cancer (NSCLC).

Justin Gainor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.